B. Klein, K. Tarte, and M. Jourdan, Survival and Proliferation Factors of Normal and Malignant Plasma Cells, International Journal of Hematology, vol.276, issue.2, pp.106-113, 2003.
DOI : 10.1007/BF02983377
URL : https://hal.archives-ouvertes.fr/inserm-00130900

D. Vos, J. Hose, D. Reme, and T. , Microarray-based understanding of normal and malignant plasma cells, Immunological Reviews, vol.61, issue.1, pp.86-104, 2006.
DOI : 10.1074/jbc.M409807200
URL : https://hal.archives-ouvertes.fr/inserm-00149827

B. Klein, J. Wijdenes, and X. Zhang, Murine anti-interleukin-6 monoclonal antibody therapy for a patient with plasma cell leukemia, Blood, vol.78, pp.1198-1204, 1991.

R. Bataille, B. Barlogie, and Z. Lu, Biologic effects of anti-interleukin-6 murine monoclonal antibody in advanced multiple myeloma, Blood, vol.86, pp.685-691, 1995.

J. Rossi, N. Fegueux, and Z. Lu, Optimizing the use of anti, p.6
URL : https://hal.archives-ouvertes.fr/inserm-00136072

J. Rossi, J. Moreaux, G. Requirand, S. Bouseida, M. Picard et al., A phase I/II study of TACI-Ig to neutralize APRIL and BLyS in patients with refractory or relapsed multiple myeloma or active previously-treated waldenström's macroglobulinemia CD200 and membrane protein interactions in the control of myeloid cells, Blood. Trends Immunol, vol.10623, issue.7, pp.285-290, 2002.

G. Wright, H. Cherwinski, and M. Foster-cuevas, Characterization of the CD200 Receptor Family in Mice and Humans and Their Interactions with CD200, The Journal of Immunology, vol.171, issue.6, pp.3034-3046, 2003.
DOI : 10.4049/jimmunol.171.6.3034

R. Gorczynski, CD200 and its receptors as targets for immunoregulation, Curr Opin Investig Drugs, vol.6, pp.483-488, 2005.

R. Gorczynski, Z. Chen, X. Fu, and H. Zeng, INCREASED EXPRESSION OF THE NOVEL MOLECULE OX-2 IS INVOLVED IN PROLONGATION OF MURINE RENAL ALLOGRAFT SURVIVAL1, Transplantation, vol.65, issue.8, pp.1106-1114, 1998.
DOI : 10.1097/00007890-199804270-00016

R. Gorczynski, Z. Cohen, X. Fu, J. Lei, R. Hoek et al., Anti-rat OX-2 blocks increased small intestinal transplant survival after portal vein immunization Down-regulation of the macrophage lineage through interaction with OX2 (CD200), Transplant Proc. Science, vol.31290, issue.12, pp.577-5781768, 1999.

R. Gorczynski, L. Lee, I. Boudakov, X. Zhang, J. Gaillard et al., Augmented Induction of CD4+CD25+ Treg using monoclonal antibodies to CD200R Reproducible obtaining of human myeloma cell lines as a model for tumor stem cell study in human multiple myeloma, Transplantation. Blood, vol.7983, issue.14, pp.1180-11833654, 1994.

C. Rebouissou, J. Wijdenes, and P. Autissier, A gp130 interleukin-6 transducerdependent SCID model of human multiple myeloma, Blood, vol.91, pp.4727-4737, 1998.

Z. Gu, J. Vos, and C. Rebouissou, Agonist anti-gp130 transducer monoclonal antibodies are human myeloma cell survival and growth factors, Leukemia, vol.14, issue.1, pp.188-197, 2000.
DOI : 10.1038/sj.leu.2401632

B. Durie, Development of an international prognostic index (IPI) for myeloma: report of the international myeloma working group, Hematology Journal, vol.4, 2003.

J. Moreaux, F. Cremer, and T. Reme, The level of TACI gene expression in myeloma cells is associated with a signature of microenvironment dependence versus a plasmablastic signature, Blood, vol.106, issue.3, pp.1021-1030, 2005.
DOI : 10.1182/blood-2004-11-4512
URL : https://hal.archives-ouvertes.fr/inserm-00129406

J. Mcwhirter, A. Kretz-rommel, and A. Saven, Antibodies selected from combinatorial libraries block a tumor antigen that plays a key role in immunomodulation, Proceedings of the National Academy of Sciences, vol.206, issue.1-2, pp.1041-1046, 2006.
DOI : 10.1016/S0022-1759(97)00087-2